Melissa L. Jampol, Amy Lerman, and Elena M. Quattrone attorneys in the Health Care & Life Sciences and Litigation practices, co-authored an article in the New Jersey Law Journal, titled “DOJ and HHS-OIG’s 2020 Health Care Fraud Takedown: Focus on 'Telefraud.'”

Following is an excerpt (see below to download the full version in PDF format):

Utilizing telehealth platforms to deliver health-care services is an area of recent, rapid expansion. Since the worldwide spread of COVID-19, safe access to health-care services has been limited, and demand for telehealth services has surged. Alexander GC, et al., Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US, JAMA Net Open (Oct. 2020) (number of telemedicine consultations increased thirtyfold to more than 35 million in 2020’s second quarter). According to Epstein Becker Green’s 2020 Telemental Health Laws survey, this year alone, many providers and patients transitioned to using telehealth platforms out of necessity. Regulators implemented measures to increase access to health care through telehealth, including waivers and other regulatory modifications related to professional licensure and use of telehealth technology, and in some cases amendments to existing and/or enacted new regulations focused on telehealth utilization.

Yet, as with all areas of health care, expansion means increased risk for enforcement. At the end of September, the U.S. Department of Justice (DOJ) and the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) demonstrated this point, announcing that in its 2020 “Takedown,” 345 defendants across 51 judicial districts have been charged with allegedly submitting more than $6 billion in false and fraudulent claims to federal health-care programs and to private payors—$4.5 billion of which related to telehealth. Press Release, DOJ, “National Health Care Fraud and Opioid Takedown Results in Charges Against 345 Defendants Responsible for More than $6 Billion in Alleged Fraud Losses,” (Sept. 30, 2020). While these enforcement actions actually occurred over numerous months preceding the press event (thus, the reference to a “takedown” is a misnomer), DOJ / HHS had not previously focused so sharply on enforcement activity involving telehealth providers. The 2020 Takedown warns the telehealth industry to pay attention to compliance infrastructures and efforts.


Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.